Thalidomide fOr the Prevention of Restenosis After Coronary ArtERy Stent Implantation

NCT01638078 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Coronary Artery Disease

Interventions

DRUG: Thalidomide
DRUG: Placebo

Sponsor

University of Roma La Sapienza